- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Compounding Bill Clears Congress
Supporters of a soon-to-be law that creates an optional new class of FDA-certified compounding pharmacies are cautiously optimistic newly passed legislation will prevent future public health crisis.
Supporters of a soon-to-be law that creates an optional new class of FDA-certified compounding pharmacies are cautiously optimistic newly passed legislation will prevent future public health crisis.
On Monday, the Senate passed by voice vote the Drug Quality and Security Act, which lawmakers hope will improve the safety of compounded and prescription drugs. The bill was already passed by the House in September in a similar manner and awaits President Obama's signature.
The legislation creates an optional FDA-certification for "outsourcing facilities" large-scale compounders that ship products to multiple states, and clear standards similar to those traditional drug manufacturers must meet. The hope is purchasers will steer toward compounders that take part in this voluntary program and away from facilities that lack the FDA's seal of approval.
Read the full story here: http://bit.ly/1aEgwe3
Source: Med Page Today
How Can Digital Care Programs Aid Those With Chronic Musculoskeletal Pain?
June 9th 2020On this episode of Managed Care Cast, we speak with Jeffrey Krauss, MD, chief medical officer of Hinge Health and Stanford Clinical assistant professor, about the efficacy of a 12-week digital care program aimed to reduce lower back and knee pain in a real-world population.
Listen
Understanding the Impact of Inappropriate Opioid Prescribing Practices
April 19th 2019Deaths from drug overdoses have become the leading cause of death for Americans under age 50, which can largely be attributed to prescription opioids. Due to the role of prescription opioids, understanding prescribing patterns and identifying inappropriate prescribing are crucial for changing the course of the epidemic.
Listen
MBSR Reduced Pain Perception in Patients With Migraine
December 19th 2020The finding about mindfulness-based stress reduction (MBSR) was a secondary outcome of the double-blinded, randomized, placebo-controlled clinical trial. The primary outcome—a reduction in the frequency of migraines—was not reached.
Read More
